Aug 5, 2021 2:01 PM
BACK TO TOP
KSE100
47,734.78
-55.10
(-0.12%)
ALLSHR
32,713.19
49.02
(0.15%)
KSE30
19,064.58
-31.31
(-0.16%)
KMI30
77,326.20
-109.38
(-0.14%)
BKTi
12,946.15
-5.85
(-0.05%)
OGTi
12,255.76
-15.88
(-0.13%)
KMIALLSHR
23,365.33
-24.83
(-0.11%)
UPP9
13,246.42
-12.20
(-0.09%)
NITPGI
9,773.18
-10.02
(-0.10%)
NBPPGI
11,798.73
-14.64
(-0.12%)
MZNPI
11,030.48
-31.24
(-0.28%)
Otsuka Pakistan Limited
PHARMACEUTICALS
Rs.309.09
0.00
(0.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Aug 2, 2021 3:34 PM
REG
FUT
ODL
Open
0.00
High
309.09
Low
309.09
Volume
200
CIRCUIT BREAKER
285.91 — 332.27
DAY RANGE
309.09 — 309.09
52-WEEK RANGE
221.01 — 345.00
Ask Price
305.00
Ask Volume
500
Bid Price
0.00
Bid Volume
0
LDCP
309.09
VAR
60.00
HAIRCUT
60.00
P/E Ratio (TTM) **
15.92
1-Year Change *
2.67%
YTD Change *
2.69%
Open
290.00
High
290.00
Low
278.20
Close
278.20
Change
-9.99%
LDCP
0.00
Volume
21
Total Trades
2
CIRCUIT BREAKER
278.18 — 340.00
DAY RANGE
278.20 — 290.00
Ask Price
320.00
Ask Volume
7
Bid Price
0.00
Bid Volume
0
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Otsuka Pakistan Limited was incorporated in Pakistan as a public limited company. The Company is engaged in the manufacturing, marketing and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods and medical equipment. The Company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan.

KEY PEOPLE
Mr. Hanif SattarCEO
Mr. Mikio BandoChairman
Mr Muhammad Amin BashirCompany Secretary
ADDRESS

30-B, Sindhi Muslim Co-operative, Housing Society, Karachi

WEBSITE

www.otsuka.pk

REGISTRAR

M/s. CDC Share Registrar Services Limited CDC House, 99 – B, Block ‘B’, S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Deloitte Yousuf Adil (Chartered Accountants)

Fiscal Year End

June

Equity Profile

Market Cap (000's)
3,739,989.00
Shares
12,100,000
Free Float
2,126,530
Free Float
17.57%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2021TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED 31-MAR-2021 View   PDF
Apr 27, 2021FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2021 View   PDF
Mar 1, 2021TRANSMISSION OF HALF YEARLY REPORT FOR THE PERIOD ENDED DECEMBER 31, 2020 View   PDF
Feb 25, 2021FINANCIAL RESULTS FOR HALF YEAR ENDED DECEMBER 31, 2020 View   PDF
Oct 29, 2020TRANSMISSION OF QUARTERLY ACCOUNTS FOR THE PERIOD ENDED SEPTEMBER 30, 2020 View   PDF
Oct 22, 2020FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2020 View   PDF
Sep 29, 2020TRANSMISSION OF ANNUAL REPORT FOR THE YEAR ENDED JUNE 30, 2020 View   PDF
Sep 1, 2020FINANCIAL RESULTS FOR YEAR ENDED JUNE 30, 2020 View   PDF
Apr 27, 2020TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED 31-MAR-2020 View   PDF
Apr 22, 2020FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2020 View   PDF
DateTitleDocument
Apr 13, 2021Board of Directors' Meeting for the period ended March 31, 2021 View   PDF
Feb 8, 2021Board of Directors' Meeting View   PDF
Oct 6, 2020Board of Directors' Meeting View   PDF
Sep 22, 2020NOTICE OF 32ND ANNUAL GENERAL MEETING OF OTSUKA PAKISTAN LIMITED View   PDF
Aug 13, 2020Board of Directors' Meeting View   PDF
Apr 7, 2020Board of Directors Meeting View   PDF
Feb 7, 2020Board of Directors' meeting View   PDF
Oct 4, 2019Board Meeting Notice View   PDF
Oct 4, 2019Board Meeting Notice
REVOKED
View   PDF
Sep 24, 2019Notice of Annual General Meeting View   PDF
DateTitleDocument
Mar 3, 2021Reappointment of Chief Executive Officer of the Company View   PDF
Sep 22, 2020CORPORATE BRIEFING SESSSION OF OTSUKA PAKISTAN LIMITED View   PDF
Apr 23, 2020CHANGE OF MANAGEMENT View   PDF
Sep 17, 2019Corporate Briefing Session Notice View   PDF
Nov 29, 2018Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 9, 2018Notice Transmission of e-Dividend View   PDF
Nov 7, 2018Appointment of the Chairman and Alternate Directors of the Company View   PDF
Oct 25, 2018Others View   PDF
Oct 16, 2018Publication of Notice of Election of Directors View   PDF
Aug 28, 2018Appointment of Company Secretary View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales2,226,9891,884,7531,869,0131,829,624
Profit after Taxation91,066(175,348)65,306109,751
EPS7.53(14.49)5.409.98
Q3 2021Q2 2021Q1 2021Q3 2020
Sales589,817546,805611,156506,080
Profit after Taxation91,30558,89143,0681,062
EPS7.554.873.560.09
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)26.9121.0230.4927.32
Net Profit Margin (%)4.09(9.30)3.496.00
EPS Growth (%)151.97(368.33)(45.89)197.84
PEG0.300.04(1.14)0.15

Payouts

DateFinancial ResultsDetailsBook Closure
August 28, 2018 12:35 PM30/06/2018(YR) 12% (D) 18/10/2018 - 24/10/2018
October 25, 2017 10:10 AM30/09/2017(IQ) 10% (B) 07/11/2017 - 13/11/2017
October 23, 2013 10:52 AM30/09/2013(IQ) 10%(I) (B) 07/11/2013 - 13/11/2013
October 17, 2012 11:26 AM30/09/2012(IQ) 10%(i) (D) 01/11/2012 - 07/11/2012
October 19, 2011 10:13 AM30/09/2011(IQ) 12.5%(i) (D) 01/11/2011 - 07/11/2011
October 14, 2010 10:09 AM30/09/2010(IQ) 15%(i) An Interim Dividend for the year ending June 30,2011. (D) 27/10/2010 - 02/11/2010
September 1, 2009 12:47 PM30/06/2OO9(YR) 15% (D) 08/10/2009 - 14/10/2009
August 26, 2008 12:04 PM30/06/2OO8(YR) 25% (D) 19/09/2008 - 25/09/2008
September 18, 2007 11:51 AM30/06/2OO7(YR) 25%(F) (D) 24/10/2007 - 30/10/2007
September 19, 2006 12:51 PM3O/O6/2OO6(YR) 22.5% (D) 24/10/2006 - 30/10/2006

Financial Reports